首页> 外国专利> CONSTRUCTING OF DNA CHIMERA FOR VACCINE DEVELOPMENT AGAINST LEISHMANIASIS AND TUBERCULOSIS

CONSTRUCTING OF DNA CHIMERA FOR VACCINE DEVELOPMENT AGAINST LEISHMANIASIS AND TUBERCULOSIS

机译:构建用于抵抗利什曼病和结核病的疫苗的DNA芯片

摘要

This invention relates to a novel recombinant chimera of DNA construct having esat-6 region of Mycobacterium tuberculosis and kinesin region of Leishmania donovani cloned together on two sides of self cleaving peptide in a DNA vaccine vector pVAX-1 wherein the Chimeric construct is operatively linked to a transcriptional promoter thus capable of self replication and expression within the mammalian cell and the process of preparation there of comprising. Analysis of the predicted protein sequence of kinesin motor domain and esat-6 domain using Promiscuous MHC Class-1 Binding Peptide Prediction Servers. Amplification of gene coding for kinesin motor domain and esat-6 domain. Cloning of kinesin esat-6 gene region in pGEM-T® vector for sequence analysis. Generation of Chimeric construct by directional cloning in pVAX-1 vector. In-vitro expression analysis of kinesin motor domain and esat-6 domain from the clones using cell free translation system and immunogenicity studies, Splenocyte proliferative and cytokines studies using the above mentioned constructs.[IN-DEL-2008-01751A]
机译:本发明涉及一种新的DNA构建体重组嵌合体,该嵌合体在DNA疫苗载体pVAX-1的自切割肽的两侧克隆有结核分枝杆菌的esat-6区和杜氏利什曼原虫的驱动蛋白区,其中该嵌合体可操作地连接于因此能够在哺乳动物细胞中自我复制和表达的转录启动子及其制备方法包括。使用混杂MHC Class-1结合肽预测服务器分析驱动蛋白运动域和esat-6域的预测蛋白序列。编码驱动蛋白运动域和esat-6域的基因的扩增。克隆pGEM-T®载体中的驱动蛋白esat-6基因区域,以进行序列分析。通过在pVAX-1载体中定向克隆产生嵌合构建体。使用无细胞翻译系统和免疫原性研究,使用上述构建体的脾细胞增殖和细胞因子研究克隆中驱动蛋白运动域和esat-6域的体外表达分析。[IN-DEL-2008-01751A]

著录项

  • 公开/公告号IN291005B

    专利类型

  • 公开/公告日2017-12-29

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN1751/DEL/2008

  • 发明设计人

    申请日2008-07-25

  • 分类号

  • 国家 IN

  • 入库时间 2022-08-21 12:51:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号